Close Lucintel Chat
Didn't Find What You're Looking for?
Call us at +1972 636 5056 or write at helpdesk@Lucintel.com
Ask an Expert Provide Custom Requirements Download Sample Report Search Available Reports
  • helpdesk@Lucintel.com
  • |
  • Call Lucintel +1 972 636 5056
  • |
  • Login
  • |
  • Register
  • |
  • Search
  • |
'
...

The Impact of COVID-19 is included in Vaccine Market. Buy it today to get an advantage.

Request the impact of COVID-19 on your product or industry


Vaccine Market Trends and Forecast

The future of the vaccine market looks promising with opportunities in the pediatrics and adults end users. The global vaccine market is expected to reach an estimated $54.6 billion by 2030 with a CAGR of -3.6% from 2023 to 2030.  In the year 2021, the vaccine market witnessed significant growth due to the outbreak of coronavirus (COVID-19) pandemic. The major drivers for this market are growing prevalence of infectious diseases, increasing consumer awareness towards immunization, and introduction of vaccination programs by governments to prevent dangerous diseases or infections, including tuberculosis, cancer, hepatitis, and influence.
Technology, Product Type, Disease Indication, Route Of Administration, and End Use
A more than 150-page report is developed to help in your business decisions. A sample figure with some insights is shown below.
Vaccine Market by Segments

Vaccine Market by Segment

The study includes trends and forecast for the global vaccine market by technology, product type, disease indication, route of administration, end use, and region, as follows:

Vaccine Market by Technology [Value ($M) Shipment Analysis from 2018 to 2030]:

  • Inactivated  Vaccine
  • Live Attenuated Vaccine
  • Conjugate and Subunit
  • Toxoid Vaccine
  • Viral Vector
  • mRNA Vaccine
  • Other Technologies

Vaccine Market by Product Type [Value ($M) Shipment Analysis from 2018 to 2030]:

  • Monovalent
  • Multivalent

Vaccine Market by Disease Indication [Value ($M) Shipment Analysis from 2018 to 2030]:

  • COVID-19
  • Influenza
  • DTP
  • Pneumococcal Diseases
  • HPV
  • Rotavirus
  • Herpes Zoster
  • Varicella
  • Other Disease Indications

Vaccine Market by Route of Administration [Value ($M) Shipment Analysis from 2018 to 2030]:

  • Intramuscular & Subcutaneous administration
  • Oral administration
  • Others

Vaccine Market by End Use [Value ($M) Shipment Analysis from 2018 to 2030]:

  • Pediatrics
  • Adults

Vaccine Market by Region [Value ($M) Shipment Analysis from 2018 to 2030]:

  • North America
  • Europe
  • Asia Pacific
  • The Rest of the World

List of Vaccines Companies

Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies, vaccine companies cater to increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the vaccine companies profiled in this report include- 

Vaccine Market Insights

  • Lucintel forecasts that other technologies will remain the largest segment over the forecast period because it helps in preventing diseases like; human papillomavirus (HPV), hepatitis B, malaria, and more. 
  • Pediatrics is expected to remain the largest end user segment due to the supportive initiatives by governments and businesses to create vaccines for pediatric population to prevent serious illness.
  • APAC will remain the largest region because of increasing urbanization and population expansion are factors in the rise of healthcare need.

Features of the Vaccine Market

  • Market Size Estimates: Vaccine market size estimation in terms of value ($M)
  • Trend And Forecast Analysis: Market trends (2018-2023) and forecast (2024-2030) by various segments and regions.
  • Segmentation Analysis: Vaccine market size by various segments, such as technology, product type, disease indication, route of administration, end use, and region
  • Regional Analysis: Vaccine market breakdown by North America, Europe, Asia Pacific, and the Rest of the World.
  • Growth Opportunities: Analysis on growth opportunities in different technologies, product types, disease indications, routes of administration, end uses, and regions for the vaccine market.
  • Strategic Analysis: This includes M&A, new product development, and competitive landscape for the vaccine market.
  • Analysis of competitive intensity of the industry based on Porter’s Five Forces model.

FAQ

Q1. What is the vaccine market size?
Answer: The global vaccine market is expected to reach an estimated $54.6 billion by 2030.
Q2. What is the growth forecast for vaccine market?
Answer: The global vaccine market is expected to grow with a CAGR of -3.6% from 2023 to 2030.
Q3. What are the major drivers influencing the growth of the vaccine market?
Answer: The major drivers for this market are growing prevalence of infectious diseases, increasing consumer awareness towards immunization, and introduction of vaccination programs by governments to prevent dangerous diseases or infections, including tuberculosis, cancer, hepatitis, and influence.
Q4. What are the major segments for vaccine market?
Answer: The future of the vaccine market looks promising with opportunities in the pediatrics and adults end use segments.
Q6. Who are the key vaccine companies?
Answer: Some of the key vaccine companies are as follows:
  • GlaxoSmithKline
  • Merck
  • Pfizer
  • Sanofi
  • CSL
Q7. Which vaccines segment will be the largest in the future?
Answer: Lucintel forecasts that conjugate will remain the largest technology segment over the forecast period because it helps in preventing invasive pneumococcal diseases. 
Q8. In vaccine market, which region is expected to be the largest in next 5 years?
Answer: North America will remain the largest region due to increasing awareness towards vaccination and supporting government policies for health welfare.
Q9. Do we receive customization in this report?
Answer: Yes, Lucintel provides 10% Customization Without any Additional Cost.

This report answers following 11 key questions

Q.1. What are some of the most promising, high-growth opportunities for the vaccine market by technology (conjugate, inactivated & subunit, live attenuated, recombinant, toxoid, viral vector, mRNA, viral vector, and others), product type (monovalent and multivalent), disease indication (influenza, pneumococcal diseases, combination vaccines, HPV, herpes zoster, meningococcal diseases, rotavirus, MMR, varicella, hepatitis, DTP, Polio, COVID 19, and others), route of administration (intramuscular & subcutaneous administration, oral administration, and others), end use (pediatrics and adults), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
Q.2. Which segments will grow at a faster pace and why?
Q.3. Which region will grow at a faster pace and why?
Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
Q.5. What are the business risks and competitive threats in this market?
Q.6. What are the emerging trends in this market and the reasons behind them?
Q.7. What are some of the changing demands of customers in the market?
Q.8. What are the new developments in the market? Which companies are leading these developments?
Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
Q.11. What M&A activity has occurred in the last five years and what has its impact been on the industry?

For any questions related to vaccine market or related to vaccine companies, vaccine market size, vaccine market share, vaccine analysis, write Lucintel analyst at email: helpdesk@lucintel.com we will be glad to get back to you soon.
Table of Contents
 
1. Executive Summary
 
2. Global Vaccine Market: Market Dynamics
2.1: Introduction, Background, and Classifications
2.2: Supply Chain
2.3: Industry Drivers and Challenges
 
3. Market Trends and Forecast Analysis from 2018 to 2030
3.1: Macroeconomic Trends (2018-2023) and Forecast (2024-2030)
3.2: Global Vaccine Market Trends (2018-2023) and Forecast (2024-2030)
3.3: Global Vaccine Market by Technology
3.3.1: Conjugate  
3.3.2: Inactivated & Subunit  
3.3.3: Live Attenuated  
3.3.4: Recombinant  
3.3.5: Toxoid  
3.3.6: Viral Vector  
3.3.7: mRNA  
3.3.8: Others  
3.4: Global Vaccine Market by Product Type
3.4.1: Monovalent  
3.4.2: Multivalent  
3.5: Global Vaccine Market by Disease Indication
3.5.1: Influenza  
3.5.2: Pneumococcal Diseases  
3.5.3: Combination Vaccines  
3.5.4: HPV  
3.5.5: Herpes Zoster  
3.5.6: Meningococcal Diseases  
3.5.7: Rotavirus  
3.5.8: MMR  
3.5.9: Varicella  
3.5.10: Hepatitis  
3.5.11: DTP  
3.5.12: Polio  
3.5.13: COVID 19  
3.5.14: Others  
3.6: Global Vaccine Market by Route of Administration
3.6.1: Intramuscular & Subcutaneous administration  
3.6.2: Oral administration  
3.6.3: Others  
3.7: Global Vaccine Market by End Use
3.7.1: Pediatrics  
3.7.2: Adults 
 
4. Market Trends and Forecast Analysis by Region from 2018 to 2030
4.1: Global Vaccine Market by Region
4.2: North American Vaccine Market
4.2.1: North American Vaccine Market by Technology: Conjugate, Inactivated & Subunit, Live Attenuated, Recombinant, Toxoid, Viral Vector, mRNA, Viral Vector, and Others
4.2.2: North American Vaccine Market by End Use: Pediatrics and Adults
4.3: European Vaccine Market 
4.3.1: European Vaccine Market by Technology: Conjugate, Inactivated & Subunit, Live Attenuated, Recombinant, Toxoid, Viral Vector, mRNA, Viral Vector, and Others
4.3.2: European Vaccine Market by End Use: Pediatrics and Adults
4.4: APAC Vaccine Market 
4.4.1: APAC Vaccine Market by Technology: Conjugate, Inactivated & Subunit, Live Attenuated, Recombinant, Toxoid, Viral Vector, mRNA, Viral Vector, and Others
4.4.2: APAC Vaccine Market by End Use: Pediatrics and Adults
4.5: ROW Vaccine Market 
4.5.1: ROW Vaccine Market by Technology: Conjugate, Inactivated & Subunit, Live Attenuated, Recombinant, Toxoid, Viral Vector, mRNA, Viral Vector, and Others
4.5.2: ROW Vaccine Market by End Use: Pediatrics and Adults
 
5. Competitor Analysis
5.1: Product Portfolio Analysis
5.2: Operational Integration
5.3: Porter’s Five Forces Analysis
 
6. Growth Opportunities and Strategic Analysis
6.1: Growth Opportunity Analysis
6.1.1: Growth Opportunities for the Global Vaccine Market by Technology
6.1.2: Growth Opportunities for the Global Vaccine Market by Product Type
6.1.3: Growth Opportunities for the Global Vaccine Market by Disease   Indication
6.1.4: Growth Opportunities for the Global Vaccine Market by Route of Administration
6.1.5: Growth Opportunities for the Global Vaccine Market by End Use
6.1.6: Growth Opportunities for the Global Vaccine Market by Region
6.2: Emerging Trends in the Global Vaccine Market 
6.3: Strategic Analysis
6.3.1: New Product Development
6.3.2: Capacity Expansion of the Global Vaccine Market 
6.3.3: Mergers, Acquisitions, and Joint Ventures in the Global Vaccine Market 
6.3.4: Certification and Licensing
 
7. Company Profiles of Leading Players
7.1: GlaxoSmithKline  
7.2: Merck  
7.3: Pfizer  
7.4: Sanofi  
7.5: CSL   
 
.

Buy full report or by chapter as follows

Price by License Type:
[-] Hide Chapter Details
[Chapter Number] [Chapter Name] [Chapter Number Of Pages] [Chapter Price]
Title/Chapter Name Pages Price
Full Report: Vaccine Market: Trends, Opportunities and Competitive Analysis [2024-2030] Full Report $ 4,850
150 - page report
Lucintel has been in the business of market research and management consulting since 2000 and has published over 1000 market intelligence reports in various markets / applications and served over 1,000 clients worldwide. This study is a culmination of four months of full-time effort performed by Lucintel's analyst team. The analysts used the following sources for the creation and completion of this valuable report:
  • In-depth interviews of the major players in this market
  • Detailed secondary research from competitors’ financial statements and published data 
  • Extensive searches of published works, market, and database information pertaining to industry news, company press releases, and customer intentions
  • A compilation of the experiences, judgments, and insights of Lucintel’s professionals, who have analyzed and tracked this market over the years.
Extensive research and interviews are conducted across the supply chain of this market to estimate market share, market size, trends, drivers, challenges, and forecasts. Below is a brief summary of the primary interviews that were conducted by job function for this report.
 
Thus, Lucintel compiles vast amounts of data from numerous sources, validates the integrity of that data, and performs a comprehensive analysis. Lucintel then organizes the data, its findings, and insights into a concise report designed to support the strategic decision-making process. The figure below is a graphical representation of Lucintel’s research process. 
 

Please sign in below to get report brochure - Vaccine Market.

At Lucintel, we respect your privacy and maintain the confidentiality of information / data provided by you
(Please enter your corporate email. * These fields are mandatory )
Have an Account / Returning Visitors?